Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents

Editorial [Hot Topic: Recent Progress in the Development of Anti-Diabetic Drugs (Guest Editor: J. Eckel)]
pp. 467-467(1)
Author: Eckel, J.

Clinical View on the Need to Develop New Anti-Diabetic Drugs
pp. 469-474(6)
Authors: Laviola, L.; Cignarelli, A.; Giorgino, F.

Insulin Analogs Revisited
pp. 475-484(10)
Author: Eckel, J.

GLP-1, Incretin Mimetics and DPP 4 Inhibitors: New Ways in the Treatment of Type 2 Diabetes
pp. 485-497(13)
Authors: Meier, Juris J.; Nauck, Michael A.

The Mode of Action of the Antidiabetic Drug Glimepiride-Beyond Insulin Secretion
pp. 499-518(20)
Author: Muller, Gunter

Glucose Transport Regulators
pp. 519-527(9)
Authors: Ben-Yakir, M.; Gruzman, A.; Alpert, E.; Sasson, S.

Serine Kinases as New Drug Targets for the Treatment of Type 2 Diabetes
pp. 529-536(8)
Author: Rondinone, Cristina M.

Editorial [ Hematopoietic Stem Cell Transplantation and Graft-Versus-Host Disease (Guest Editor: T. Iwasaki)]
pp. 537-537(1)
Author: Iwasaki, Tsuyoshi

Graft Versus Host Disease
pp. 539-545(7)
Authors: Ferrara, J. L.M.; Mineishi, S.

A New Bone Marrow Transplantation Method for the Prevention of Graft- Versus-Host Disease
pp. 547-554(8)
Author: Ikehara, Susumu

In Vitro and In Vivo Sirolimus for Modulation of Allogeneic Hematopoietic Stem Cell Transplantation
pp. 555-564(10)
Authors: Fowler, Daniel H.; Gress, Ronald E.

Protective Growth Factors for Graft-Versus-Host Disease
pp. 565-573(9)
Author: Iwasaki, Tsuyoshi

The Parent-into-F1 Model of Graft-vs-Host Disease as a Model of In Vivo T Cell Function and Immunomodulation
pp. 575-583(9)
Authors: Pulaiev, R. A.; Puliaeva, I. A.; Ryan, A. E.; Via, C. S.

GVHD: Complication and Challenge to Successful Allogeneic Hematopoietic Cell Transplantation
pp. 585-597(13)
Author: Levy, Robert B.